Abstract
Recently, lytic bacteriophages (phages) have been focused on treating bacterial infectious diseases. We investigated the protective efficacy of a novel Pseudomonas aeruginosa phage, PA1Ø, in normal and neutropenic mice. A lethal dose of P. aeruginosa PAO1 was administered via the intraperitoneal route and a single
dose of PA1Ø with different multiplicities of infection (MOI) was treated into infected mice. Immunocompetent mice infected with P. aeruginosa PAO1 were successfully protected by PA1Ø of 1 MOI, 10 MOI or 100 MOI with 80% to 100% survival rate. No viable bacteria were found in organ samples after 48 h of the phage treatment. Phage clearing patterns were different in the presence or absence of host bacteria but PA1Ø disappeared from all organs after 72 h except spleen in the presence of host bacteria. On the contrary, PA1Ø treatment could not protect neutropenic mice infected with P. aeruginosa PAO1 even though could extend their lives for a short time. In in vitro phage-neutrophil bactericidal test, a stronger bactericidal effect was observed in phage-neutrophil co-treatment than in phage single treatment without neutrophils, suggesting phage-neutrophil co-work is essential for the efficient killing of bacteria in the mouse model. In conclusion, PA1Ø can be possibly utilized in future phage therapy endeavors since it exhibited strong protective effects against virulent P. aeruginosa infection.
Citations
Citations to this article as recorded by

- Isolation and characterization of a potent bacteriophage KA targeting an antibiotic-resistant human pathogenic strain of Klebsiella pneumoniae KP1
Aneela Nawaz, Nauman Ahmed Khalid, Sidra Zaheer, Muhammad Ismail Khan, Ali Khalid, Aamer Ali Shah, Malik Badshah, Samiullah Khan
Microbial Pathogenesis.2026; 210: 108150. CrossRef - Phage-induced protection against lethal bacterial reinfection
Yikun Xing, Haroldo J. Hernandez Santos, Ling Qiu, Samantha R. Ritter, Jacob J. Zulk, Rachel Lahowetz, Kathryn A. Patras, Austen L. Terwilliger, Anthony W. Maresso
Proceedings of the National Academy of Sciences.2025;[Epub] CrossRef - Bacteriophages as an alternative strategy for the treatment of drug resistant bacterial infections: Current approaches and future perspectives
Abayeneh Girma
The Cell Surface.2025; 14: 100149. CrossRef - Multi-strain phage induced clearance of bacterial infections
Jacopo Marchi, Chau Nguyen Ngoc Minh, Laurent Debarbieux, Joshua S Weitz, Rob J De Boer
PLOS Computational Biology.2025; 21(2): e1012793. CrossRef - Overcoming Pseudomonas aeruginosa in Chronic Suppurative Lung Disease: Prevalence, Treatment Challenges, and the Promise of Bacteriophage Therapy
Jagdev Singh, Melinda Solomon, Jonathan Iredell, Hiran Selvadurai
Antibiotics.2025; 14(5): 427. CrossRef - Isolation and identification of a newly discovered broad-spectrum Acinetobacter baumannii phage and therapeutic validation against pan-resistant Acinetobacter baumannii
Miaomiao Lin, Lele Xiong, Wen Li, Lingyan Xiao, Wei Zhang, Xiaogui Zhao, Yishan Zheng
Virologica Sinica.2025; 40(4): 587. CrossRef - Overcoming antimicrobial resistance: Phage therapy as a promising solution to combat ESKAPE pathogens
Ritu Raj Patel, Pandey Priya Arun, Sudhir Kumar Singh, Meenakshi Singh
International Journal of Antimicrobial Agents.2025; 66(6): 107640. CrossRef - Phage-mediated TLR2 signaling attenuates intracellular Mycobacterium abscessus survival in macrophages
Hannah Kapoor, Aaron M. Maves, Madeline A. Bowder, Lia Danelishvili
Scientific Reports.2025;[Epub] CrossRef - Neutrophils, not macrophages, aid phage-mediated control of pulmonary Pseudomonas aeruginosa infection
Chantal Weissfuss, Karen Hoffmann, Ulrike Behrendt, Magdalena Bürkle, Shailey G. Twamley, Imke H. E. Korf, Katharina Ahrens, Christine Rohde, Christian M. Zobel, Laurent Debarbieux, Jean-Damien Ricard, Martin Witzenrath, Geraldine Nouailles
Frontiers in Immunology.2025;[Epub] CrossRef - Mycobacteriophages: therapeutic approach for mycobacterial infections
Sunil Kumar Raman, D.V. Siva Reddy, Vikas Jain, Urmi Bajpai, Amit Misra, Amit Kumar Singh
Drug Discovery Today.2024; 29(7): 104049. CrossRef - Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications
Elaheh Alipour-Khezri, Mikael Skurnik, Gholamreza Zarrini
Viruses.2024; 16(7): 1051. CrossRef - Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo
Eleri A. Ashworth, Rosanna C. T. Wright, Rebecca K. Shears, Janet K. L. Wong, Akram Hassan, James P. J. Hall, Aras Kadioglu, Joanne L. Fothergill
Nature Communications.2024;[Epub] CrossRef - Phage-inspired strategies to combat antibacterial resistance
Mianzhi Wang, Junxuan Zhang, Jingyi Wei, Lei Jiang, Li Jiang, Yongxue Sun, Zhenling Zeng, Zhiqiang Wang
Critical Reviews in Microbiology.2024; 50(2): 196. CrossRef - Bacteriophages isolated from mouse feces attenuates pneumonia mice caused by Pseudomonas aeruginosa
Nuttawut Sutnu, Wiwat Chancharoenthana, Supitcha Kamolratanakul, Pornpimol Phuengmaung, Uthaibhorn Singkham-In, Chiratchaya Chongrak, Sirikan Montathip, Dhammika Leshan Wannigama, Tanittha Chatsuwan, Puey Ounjai, Marcus J. Schultz, Asada Leelahavanichkul,
PLOS ONE.2024; 19(7): e0307079. CrossRef - Evaluation of the impact of repeated intravenous phage doses on mammalian host–phage interactions
Xin Tan, Kai Chen, Zhihuan Jiang, Ziqiang Liu, Siyun Wang, Yong Ying, Jieqiong Zhang, Shengjian Yuan, Zhipeng Huang, Ruyue Gao, Min Zhao, Aoting Weng, Yongqing Yang, Huilong Luo, Daizhou Zhang, Yingfei Ma, Kristin N. Parent
Journal of Virology.2024;[Epub] CrossRef - The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo
Arne Echterhof, Tejas Dharmaraj, Arya Khosravi, Robert McBride, Lynn Miesel, Ju-Hsin Chia, Patrick M. Blankenberg, Kun-Yuan Lin, Chien-Chang Shen, Yu-Ling Lee, Yu-Chuan Yeh, Wei Ting Liao, Francis G. Blankenberg, Krystyna Dąbrowska, Derek F. Amanatullah,
JCI Insight.2024;[Epub] CrossRef -
In vivo safety evaluation and tracing of arginylglycylaspartic acid-engineered phage nanofiber in murine model
Kshitiz Raj Shrestha, Sehoon Kim, Anna Jo, Murali Ragothaman, So Young Yoo
Journal of Materials Chemistry B.2024; 12(40): 10258. CrossRef -
Metapopulation model of phage therapy of an acute
Pseudomonas aeruginosa
lung infection
Rogelio A. Rodriguez-Gonzalez, Quentin Balacheff, Laurent Debarbieux, Jacopo Marchi, Joshua S. Weitz, Oleg A. Igoshin
mSystems.2024;[Epub] CrossRef - Pharmacokinetics and Biodistribution of Phages and their Current Applications in Antimicrobial Therapy
Dayeon Kang, Damayanti Bagchi, Irene A. Chen
Advanced Therapeutics.2024;[Epub] CrossRef - Phage therapy: A primer for orthopaedic trauma surgeons
Baixing Chen, T.Fintan Moriarty, Willem-Jan Metsemakers, Marco Chittò
Injury.2024; 55: 111847. CrossRef - Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections
Maria Siopi, Dimitrios Skliros, Paschalis Paranos, Nikoletta Koumasi, Emmanouil Flemetakis, Spyros Pournaras, Joseph Meletiadis, Graeme N. Forrest
Clinical Microbiology Reviews.2024;[Epub] CrossRef - Phage-Based Therapy in Combination with Antibiotics: A Promising Alternative against Multidrug-Resistant Gram-Negative Pathogens
Cleo Anastassopoulou, Stefanos Ferous, Aikaterini Petsimeri, Georgia Gioula, Athanasios Tsakris
Pathogens.2024; 13(10): 896. CrossRef - Leveraging mathematical modeling framework to guide regimen strategy for phage therapy
Zhiyuan Yu, Tiffany Luong, Selenne Banuelos, Andrew Sue, Hwayeon Ryu, Rebecca Segal, Dwayne R. Roach, Qimin Huang, Jaehee Kim
PLOS Complex Systems.2024; 1(3): e0000015. CrossRef - Phage therapy: a revolutionary shift in the management of bacterial infections, pioneering new horizons in clinical practice, and reimagining the arsenal against microbial pathogens
Subhash Lal Karn, Mayank Gangwar, Rajesh Kumar, Satyanam Kumar Bhartiya, Gopal Nath
Frontiers in Medicine.2023;[Epub] CrossRef - A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa
Aliaa Abdelghafar, Amira El-Ganiny, Ghada Shaker, Momen Askoura
European Journal of Clinical Microbiology & Infectious Diseases.2023; 42(10): 1207. CrossRef - Phage-host-immune system dynamics in bacteriophage therapy: basic principles and mathematical models
Dongwoo Chae
Translational and Clinical Pharmacology.2023; 31(4): 167. CrossRef - BACTERIOPHAGE M13 MODULATES THE SEPSIS-RELATED INFLAMMATORY RESPONSES AND ORGAN DAMAGE IN A CLP MODEL
Arezou Rahimi, Sara Soudi, Saeid Vakilian, Fatemeh Jamshidi-Adegani, Majid Sadeghizadeh, Sulaiman Al-Hashmi
Shock.2023; 59(3): 493. CrossRef - Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
Dwayne R. Roach, Benoît Noël, Sylvie Chollet-Martin, Mathieu de Jode, Vanessa Granger, Laurent Debarbieux, Luc de Chaisemartin
Viruses.2023; 15(8): 1726. CrossRef - Translating phage therapy into the clinic: Recent accomplishments but continuing challenges
Aleksandra Petrovic Fabijan, Jonathan Iredell, Katarzyna Danis-Wlodarczyk, Razieh Kebriaei, Stephen T. Abedon
PLOS Biology.2023; 21(5): e3002119. CrossRef - Phage therapy for hidradenitis suppurativa: a unique challenge and possible opportunity for personalized treatment of a complex, inflammatory disease
Lene Bens, Sabrina I Green, Daan Jansen, Tom Hillary, Tine Vanhoutvin, Jelle Matthijnssens, João Sabino, Séverine Vermeire, An Van Laethem, Jeroen Wagemans, Rob Lavigne
Clinical and Experimental Dermatology.2023; 48(11): 1221. CrossRef - Determination of phage load and administration time in simulated occurrences of antibacterial treatments
Steffen Plunder, Markus Burkard, Ulrich M. Lauer, Sascha Venturelli, Luigi Marongiu
Frontiers in Medicine.2022;[Epub] CrossRef - Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations
Georgia Mitropoulou, Angela Koutsokera, Chantal Csajka, Sylvain Blanchon, Alain Sauty, Jean-Francois Brunet, Christophe von Garnier, Grégory Resch, Benoit Guery
European Respiratory Review.2022; 31(166): 220121. CrossRef - Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection
Tomoya Suda, Tomoko Hanawa, Mayuko Tanaka, Yasunori Tanji, Kazuhiko Miyanaga, Sanae Hasegawa-Ishii, Ken Shirato, Takako Kizaki, Takeaki Matsuda
Scientific Reports.2022;[Epub] CrossRef - Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases
Daniel R. Laucirica, Stephen M. Stick, Luke W. Garratt, Anthony Kicic
Frontiers in Medicine.2022;[Epub] CrossRef - Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans
Panagiotis Zagaliotis, Jordyn Michalik-Provasek, Jason Gill, Thomas Walsh
Pathogens and Immunity.2022; 7(2): 1. CrossRef - Circulation of Fluorescently Labelled Phage in a Murine Model
Zuzanna Kaźmierczak, Joanna Majewska, Magdalena Milczarek, Barbara Owczarek, Krystyna Dąbrowska
Viruses.2021; 13(2): 297. CrossRef - Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections
Dana Holger, Razieh Kebriaei, Taylor Morrisette, Katherine Lev, Jose Alexander, Michael Rybak
Antibiotics.2021; 10(5): 556. CrossRef - Characteristics of a Bacteriophage, vB_Kox_ZX8, Isolated From Clinical Klebsiella oxytoca and Its Therapeutic Effect on Mice Bacteremia
Ping Li, Yangheng Zhang, Fuhua Yan, Xin Zhou
Frontiers in Microbiology.2021;[Epub] CrossRef - Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections
Alan A. Schmalstig, Soha Freidy, Patrick O. Hanafin, Miriam Braunstein, Gauri G. Rao
Clinical Pharmacology & Therapeutics.2021; 109(6): 1443. CrossRef - A single dose of a virulent bacteriophage vB PaeP-SaPL, rescues bacteremic mice infected with multi drug resistant Pseudomonas aeruginosa
Iqbal Ahmad Alvi, Muhammad Asif, Shafiq ur Rehman
Virus Research.2021; 292: 198250. CrossRef - Antiviral effect of a bacteriophage on murine norovirus replication via modulation of the innate immune response
Lili Zhang, Chang Ma, Jie Liu, Khashayar Shahin, Xiang Hou, Lichang Sun, Heye Wang, Ran Wang
Virus Research.2021; 305: 198572. CrossRef - Bacteriophages as an Alternative Method for Control of Zoonotic and Foodborne Pathogens
Mohammed Mijbas Mohammed Alomari, Marta Dec, Renata Urban-Chmiel
Viruses.2021; 13(12): 2348. CrossRef - Formulation strategies for bacteriophages to target intracellular bacterial pathogens
Wei Yan, Parikshit Banerjee, Miao Xu, Subhankar Mukhopadhyay, Margaret Ip, Nicholas B. Carrigy, David Lechuga-Ballesteros, Kenneth Kin Wah To, Sharon S.Y. Leung
Advanced Drug Delivery Reviews.2021; 176: 113864. CrossRef - Characterization of a Novel Bacteriophage Henu2 and Evaluation of the Synergistic Antibacterial Activity of Phage-Antibiotics
Xianghui Li, Tongxin Hu, Jiacun Wei, Yuhua He, Abualgasim Elgaili Abdalla, Guoying Wang, Yanzhang Li, Tieshan Teng
Antibiotics.2021; 10(2): 174. CrossRef - Therapeutic Perspectives and Mechanistic Insights of Phage Therapy in Allotransplantation
Kenneth J. Dery, Andrzej Górski, Ryszard Międzybrodzki, Douglas G. Farmer, Jerzy W. Kupiec-Weglinski
Transplantation.2021; 105(7): 1449. CrossRef - How to kill Pseudomonas—emerging therapies for a challenging pathogen
Luke N. Yaeger, Victoria E. Coles, Derek C. K. Chan, Lori L. Burrows
Annals of the New York Academy of Sciences.2021; 1496(1): 59. CrossRef - Bacteriophages and the Immune System
Medeea Popescu, Jonas D. Van Belleghem, Arya Khosravi, Paul L. Bollyky
Annual Review of Virology.2021; 8(1): 415. CrossRef - Synergistic Killing and Re-Sensitization of Pseudomonas aeruginosa to Antibiotics by Phage-Antibiotic Combination Treatment
Emily Engeman, Helen R. Freyberger, Brendan W. Corey, Amanda M. Ward, Yunxiu He, Mikeljon P. Nikolich, Andrey A. Filippov, Stuart D. Tyner, Anna C. Jacobs
Pharmaceuticals.2021; 14(3): 184. CrossRef - Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model
Gunaraj Dhungana, Roshan Nepal, Madhav Regmi, Rajani Malla
Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef - Interactions of Bacteriophages with Animal and Human Organisms—Safety Issues in the Light of Phage Therapy
Magdalena Podlacha, Łukasz Grabowski, Katarzyna Kosznik-Kawśnicka, Karolina Zdrojewska, Małgorzata Stasiłojć, Grzegorz Węgrzyn, Alicja Węgrzyn
International Journal of Molecular Sciences.2021; 22(16): 8937. CrossRef - A Review of Using Mathematical Modeling to Improve Our Understanding of Bacteriophage, Bacteria, and Eukaryotic Interactions
Kathryn M. Styles, Aidan T. Brown, Antonia P. Sagona
Frontiers in Microbiology.2021;[Epub] CrossRef - Impact of Frequent Administration of Bacteriophage on Therapeutic Efficacy in an A. baumannii Mouse Wound Infection Model
Michael D. Rouse, Joshua Stanbro, Jessica A. Roman, Michelle A. Lipinski, Anna Jacobs, Biswaijt Biswas, James Regeimbal, Matthew Henry, Michael G. Stockelman, Mark P. Simons
Frontiers in Microbiology.2020;[Epub] CrossRef - Phage therapy efficacy: a review of the last 10 years of preclinical studies
Luís D. R. Melo, Hugo Oliveira, Diana P. Pires, Krystyna Dabrowska, Joana Azeredo
Critical Reviews in Microbiology.2020; 46(1): 78. CrossRef - RLP, a bacteriophage of the family Podoviridae, rescues mice from bacteremia caused by multi-drug-resistant Pseudomonas aeruginosa
Iqbal Ahmad Alvi, Muhammad Asif, Rabia Tabassum, Rehan Aslam, Zaigham Abbas, Shafiq ur Rehman
Archives of Virology.2020; 165(6): 1289. CrossRef - Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections
Patrick R. Secor, Elizabeth B. Burgener, M. Kinnersley, Laura K. Jennings, Valery Roman-Cruz, Medeea Popescu, Jonas D. Van Belleghem, Naomi Haddock, Conner Copeland, Lia A. Michaels, Christiaan R. de Vries, Qingquan Chen, Julie Pourtois, Travis J. Wheeler
Frontiers in Immunology.2020;[Epub] CrossRef - Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies
Mihnea R. Mangalea, Breck A. Duerkop, Karen M. Ottemann
Infection and Immunity.2020;[Epub] CrossRef - Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review
Krystyna Dąbrowska
Medicinal Research Reviews.2019; 39(5): 2000. CrossRef - Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies
Krystyna Dąbrowska, Stephen T. Abedon
Microbiology and Molecular Biology Reviews.2019;[Epub] CrossRef - Biological challenges of phage therapy and proposed solutions: a literature review
Katherine M Caflisch, Gina A Suh, Robin Patel
Expert Review of Anti-infective Therapy.2019; 17(12): 1011. CrossRef - Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System
Jonas D. Van Belleghem, Krystyna Dąbrowska, Mario Vaneechoutte, Jeremy J. Barr, Paul L. Bollyky
Viruses.2018; 11(1): 10. CrossRef - Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation
Rachel Yoon Kyung Chang, Ke Chen, Jiping Wang, Martin Wallin, Warwick Britton, Sandra Morales, Elizabeth Kutter, Jian Li, Hak-Kim Chan
Antimicrobial Agents and Chemotherapy.2018;[Epub] CrossRef - Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review
Martina Rossitto, Ersilia V. Fiscarelli, Paola Rosati
Frontiers in Microbiology.2018;[Epub] CrossRef - Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics
Ewa Jończyk-Matysiak, Beata Weber-Dąbrowska, Barbara Owczarek, Ryszard Międzybrodzki, Marzanna Łusiak-Szelachowska, Norbert Łodej, Andrzej Górski
Viruses.2017; 9(6): 150. CrossRef - Modeling the synergistic elimination of bacteria by phage and the innate immune system
Chung Yin (Joey) Leung, Joshua S. Weitz
Journal of Theoretical Biology.2017; 429: 241. CrossRef -
Characterization and complete genome sequence analysis of two
Myoviral
bacteriophages infecting clinical carbapenem‐resistant
Acinetobacter baumannii
isolates
J. Jeon, R. D'Souza, N. Pinto, C.‐M. Ryu, J. Park, D. Yong, K. Lee
Journal of Applied Microbiology.2016; 121(1): 68. CrossRef - Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections
Diana P. Pires, Diana Vilas Boas, Sanna Sillankorva, Joana Azeredo, S. P. Goff
Journal of Virology.2015; 89(15): 7449. CrossRef - The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes
Ewa Jończyk-Matysiak, Marzanna Łusiak-Szelachowska, Marlena Kłak, Barbara Bubak, Ryszard Międzybrodzki, Beata Weber-Dąbrowska, Maciej Żaczek, Wojciech Fortuna, Paweł Rogóż, Sławomir Letkiewicz, Krzysztof Szufnarowski, Andrzej Górski
Journal of Immunology Research.2015; 2015: 1. CrossRef - Bacteriophages and Biofilms
David Harper, Helena Parracho, James Walker, Richard Sharp, Gavin Hughes, Maria Werthén, Susan Lehman, Sandra Morales
Antibiotics.2014; 3(3): 270. CrossRef - Phage fitness may help predict phage therapy efficacy
Heather M Lindberg, Kurt A McKean, Ing-Nang Wang
Bacteriophage.2014; 4(4): e964081. CrossRef - Bacteriophages and Their Derivatives as Biotherapeutic Agents in Disease Prevention and Treatment
Mohamed Elbreki, R. Paul Ross, Colin Hill, Jim O'Mahony, Olivia McAuliffe, Aidan Coffey
Journal of Viruses.2014; 2014: 1. CrossRef - Phage Therapy Is Effective against Infection by Mycobacterium ulcerans in a Murine Footpad Model
Gabriela Trigo, Teresa G. Martins, Alexandra G. Fraga, Adhemar Longatto-Filho, António G. Castro, Joana Azeredo, Jorge Pedrosa, Christian Johnson
PLoS Neglected Tropical Diseases.2013; 7(4): e2183. CrossRef - Use of bacteriophages in the treatment ofPseudomonas aeruginosainfections
James Soothill
Expert Review of Anti-infective Therapy.2013; 11(9): 909. CrossRef